<DOC>
	<DOCNO>NCT01726777</DOCNO>
	<brief_summary>Type 2 diabetes ( T2D ) increasingly common serious condition . Studies show low vitamin D level associate increase diabetes risk vitamin D may protect diabetes reduce chronic inflammation improve insulin sensitivity insulin secretion . However , study able show vitamin D actually reduce post-prandial blood glucose level , clinically relevant marker diabetes . Previously investigator show cheddar cheese low-fat cheese fortify high level vitamin D cheese least effective vitamin D supplement raise blood vitamin D level . The main purpose study see whether vitamin D enrich cheese improve oral glucose tolerance ( reduce blood glucose 2 hour consume drink contain 75g sugar ) people low vitamin D level risk develop T2D . Other aims determine effect vitamin D may insulin sensitivity , insulin secretion , marker inflammation , blood cholesterol level , safety marker urinary calcium excretion .</brief_summary>
	<brief_title>Effect Vitamin D Supplementation Glucose Tolerance Subjects Risk Diabetes With Low Vitamin D .</brief_title>
	<detailed_description>Type 2 diabetes ( T2D ) increasingly prevalent serious condition whose risk appear increase low serum vitamin D concentration . Epidemiological study show association increase diabetes risk low serum vitamin D study suggest vitamin D may protect diabetes reduce chronic inflammation improve insulin sensitivity insulin secretion . Although clinical study show effect , study able show vitamin D supplementation reduce post-prandial blood glucose , clinically relevant marker diabetes dysglycemia . Previously , investigator show cheddar cheese low-fat cheese fortify high level vitamin D3 ( 28,000IU/ 30g portion ) , form , least effective vitamin D3 supplement raise serum vitamin D concentration . Since post-prandial glucose sensitive change insulin sensitivity main purpose study determine effect vitamin D supplementation oral glucose tolerance ( ie . serum glucose 2h 75g oral glucose ) individual risk develop T2D . Secondary objective determine effect vitamin D supplementation insulin sensitivity , insulin secretion , inflammatory marker , blood lipid marker safety include serum parathyroid hormone level urinary calcium excretion .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>male nonpregnant , nonlactating female , age 1875 volunteered participate signing consent form BMI &lt; 40kg/ m2 vitamin D insufficient , define : serum 25 ( OH ) vitamin D3 ( 25 ( OH ) D ) concentration ≤65nmol/ L increase risk diabetes , define : FINDRISC score &gt; 10 Caucasians &gt; 6 nonCaucasians OR presence metabolic syndrome dysglycemia , define : fasting serum glucose 5.6 6.9 mmol/L , inclusive OR HbA1c 0.054 0.064 , inclusive systolic blood pressure ≤150/95 mmHg treat hypertension ≤140/90 mmHg treatment hypertension . take prescription drug , stable ( least 6 week ) dose birth control pill , drug ( ) use treat hypertension , hyperlipidemia , depression mental illness hypothyroid . take supplement , stable ( least 6 week ) dose supplement ( ) . subject meet inclusion criterion history renal failure liver disease serum creatinine &gt; 1.8 time upper limit normal ( ULN ) serum aspartate alanine transaminase ( AST , ALT ) &gt; 3 time ULN current use drug drug treat diabetes use steroid pancreatic enzyme within 6 week randomization , change dose supplement drug ( ) use treat hypertension , hyperlipidemia , depression mental illness hypothyroid . use antibiotic within 3 month . medical surgical event require hospitalization within 3 month randomization presence condition affect nutrient absorption intolerance cheese plan travel outside Canada 14 consecutive day trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Randomized control clinical trial</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Oral glucose tolerance</keyword>
	<keyword>Blood glucose</keyword>
	<keyword>Insulin resistance</keyword>
</DOC>